#Caris_Life_Sciences
LightNews LightNews
newsen.bsky.social
Caris Life Sciences Reveals Insights into Metastatic Breast Cancer Treatment Resistance and Responses#United_States#Caris_Life_Sciences#Irving#Metastatic_Breast_Cancer#Trastuzumab_Deruxtecan
Caris Life Sciences Reveals Insights into Metastatic Breast Cancer Treatment Resistance and Responses
Caris Life Sciences unveils crucial findings on the varying responses of metastatic breast cancer patients to Trastuzumab Deruxtecan, enhancing understanding of treatment resistance dynamics.
third-news.com
January 28, 2026 at 1:46 PM
newsen.bsky.social
Caris Life Sciences and Everlywell Join Forces for Revolutionary Cancer Detection Technology#USA#Caris_Life_Sciences#Irving#Everlywell#MCED_Assay
Caris Life Sciences and Everlywell Join Forces for Revolutionary Cancer Detection Technology
Caris Life Sciences partners with Everlywell to revolutionize cancer detection with a new blood assay called Caris Detect, combining advanced technologies for early diagnosis.
third-news.com
January 12, 2026 at 1:17 PM
newsen.bsky.social
Caris Life Sciences Set to Showcase Innovations at 44th J.P. Morgan Healthcare Conference#United_States#San_Francisco#Caris_Life_Sciences#Precision_Medicine#AI_TechBio
Caris Life Sciences Set to Showcase Innovations at 44th J.P. Morgan Healthcare Conference
Caris Life Sciences is gearing up to present its advanced healthcare solutions at the upcoming 44th Annual J.P. Morgan Healthcare Conference, highlighting its innovation in precision medicine.
third-news.com
January 5, 2026 at 1:42 PM
newsen.bsky.social
Caris Precision Oncology Alliance Expands with Providence Swedish Cancer Institute Joining Forces#USA#Seattle#Caris_Life_Sciences#Precision_Oncology#Providence_Swedish
Caris Precision Oncology Alliance Expands with Providence Swedish Cancer Institute Joining Forces
The Caris Precision Oncology Alliance adds Providence Swedish Cancer Institute, enhancing collaboration in precision oncology and improving patient outcomes.
third-news.com
December 19, 2025 at 1:36 PM
newsen.bsky.social
Caris Life Sciences Teams Up with Genentech for Cancer Research Breakthroughs#United_States#Cancer_Research#Caris_Life_Sciences#Irving#Genentech
Caris Life Sciences Teams Up with Genentech for Cancer Research Breakthroughs
Caris Life Sciences has partnered with Genentech to explore new cancer treatment targets, aiming to enhance precision medicine and address unmet clinical needs.
third-news.com
December 16, 2025 at 2:03 PM
newsen.bsky.social
ECOG-ACRIN and Caris Life Sciences Present AI Innovations for Breast Cancer Prognosis#United_States#Caris_Life_Sciences#AI_Models#ECOG-ACRIN#Philadelphia_and_Irving
ECOG-ACRIN and Caris Life Sciences Present AI Innovations for Breast Cancer Prognosis
Groundbreaking AI models showcased by ECOG-ACRIN and Caris demonstrate improved methods for assessing breast cancer recurrence risks, promising enhanced patient outcomes.
third-news.com
December 10, 2025 at 10:51 PM
newsen.bsky.social
Caris Life Sciences Unveils 19 Groundbreaking Studies at 2025 San Antonio Breast Cancer Symposium#United_States#San_Antonio#Caris_Life_Sciences#Breast_Cancer#SABCS
Caris Life Sciences Unveils 19 Groundbreaking Studies at 2025 San Antonio Breast Cancer Symposium
At the 2025 San Antonio Breast Cancer Symposium, Caris Life Sciences will present 19 pivotal studies focused on diverse breast cancer subtypes and precision oncology.
third-news.com
December 4, 2025 at 2:07 PM
newsen.bsky.social
Caris Life Sciences Announces Inclusion of UAMS Cancer Institute in Oncology Alliance#United_States#Caris_Life_Sciences#Little_Rock#Precision_Oncology#UAMS_Cancer_Institute
Caris Life Sciences Announces Inclusion of UAMS Cancer Institute in Oncology Alliance
Caris Life Sciences has welcomed UAMS' Winthrop P. Rockefeller Cancer Institute into its Precision Oncology Alliance, enhancing cancer care and research opportunities.
third-news.com
December 2, 2025 at 2:19 PM
newsen.bsky.social
Caris Life Sciences Celebrates New Class of Oncology Fellows for 2025/2026#USA#oncology#Caris_Life_Sciences#Irving#Precision_Medicine
Caris Life Sciences Celebrates New Class of Oncology Fellows for 2025/2026
The Caris Precision Oncology Alliance has selected 15 physician-scientists for its 2025/2026 Fellows Forum, focusing on precision medicine training and research.
third-news.com
November 21, 2025 at 1:35 PM
newsen.bsky.social
Caris Life Sciences Sets Its Sights on Investor Conferences in Late 2025#United_States#Investor_Conferences#Caris_Life_Sciences#Irving#Precision_Medicine
Caris Life Sciences Sets Its Sights on Investor Conferences in Late 2025
Caris Life Sciences will be attending multiple investor conferences in late 2025, focusing on healthcare innovation and precision medicine.
third-news.com
November 17, 2025 at 1:59 PM
newsen.bsky.social
Caris Life Sciences Achieves Record Revenue Growth in Q3 2025 Report#USA#Caris_Life_Sciences#Irving#Precision_Medicine#AI_TechBio
Caris Life Sciences Achieves Record Revenue Growth in Q3 2025 Report
Caris Life Sciences experienced a remarkable 113% revenue increase in Q3 2025, reinforcing its position as an AI TechBio leader.
third-news.com
November 5, 2025 at 9:27 PM
newsen.bsky.social
Caris Life Sciences Identifies TET2 as a Key Biomarker for Immunotherapy Success#United_States#Caris_Life_Sciences#Irving#Immune_Checkpoint_Inhibitors#TET2_Clonal_Hematopoiesis
Caris Life Sciences Identifies TET2 as a Key Biomarker for Immunotherapy Success
Caris Life Sciences has unveiled research showing TET2 clonal hematopoiesis as a novel biomarker that could improve responses to immunotherapy in cancer treatment.
third-news.com
October 29, 2025 at 12:46 PM
newsen.bsky.social
Caris Life Sciences Showcases Innovative Cancer Research at ESMO 2025 Congress#United_States#Caris_Life_Sciences#Irving#Precision_Medicine#ESMO_Congress
Caris Life Sciences Showcases Innovative Cancer Research at ESMO 2025 Congress
Caris Life Sciences is set to present six groundbreaking studies at the ESMO 2025 Congress, showcasing advancements in precision medicine and multiomics.
third-news.com
October 14, 2025 at 1:35 PM
newsen.bsky.social
Caris Life Sciences Validates MI Cancer Seek®: A Breakthrough in Precision Oncology#United_States#Caris_Life_Sciences#Irving#Precision_Medicine#MI_Cancer_Seek
Caris Life Sciences Validates MI Cancer Seek®: A Breakthrough in Precision Oncology
Caris Life Sciences has validated its FDA-approved MI Cancer Seek® diagnostic tool, advancing the field of precision oncology.
third-news.com
August 15, 2025 at 12:33 PM
newsen.bsky.social
New Insights on Therapy Sequencing for Breast Cancer Patients from Caris Life Sciences#USA#Caris_Life_Sciences#Irving#T-DXd#SG
New Insights on Therapy Sequencing for Breast Cancer Patients from Caris Life Sciences
Discover the latest findings from Caris Life Sciences on optimal therapy sequencing for breast cancer treatments, enhancing patient care and outcomes.
third-news.com
August 13, 2025 at 12:57 PM
newsen.bsky.social
Caris Life Sciences Reports Strong Financial Growth in Q2 2025 with Major Advances in AI TechBio Solutions#United_States#Caris_Life_Sciences#Irving#Precision_Medicine#AI_TechBio
Caris Life Sciences Reports Strong Financial Growth in Q2 2025 with Major Advances in AI TechBio Solutions
Caris Life Sciences has announced impressive financial results for the second quarter of 2025, highlighting significant growth and progress in their AI-driven approach to precision medicine.
third-news.com
August 12, 2025 at 8:13 PM
newsen.bsky.social
Caris Life Sciences Unveils Groundbreaking Study Highlighting AI's Role in Breast Cancer Survival Rates#United_States#Caris_Life_Sciences#Irving#Breast_Cancer#AI-based_model
Caris Life Sciences Unveils Groundbreaking Study Highlighting AI's Role in Breast Cancer Survival Rates
A new study published by Caris Life Sciences shows that AI Signature-positive breast cancer patients experience significantly longer survival rates compared to AI-negative patients when treated with checkpoint inhibitors.
third-news.com
August 6, 2025 at 12:59 PM
newsen.bsky.social
Caris Life Sciences Unveils Groundbreaking AI Tool for Accurate Tumor Diagnosis and Treatment Decisions#United_States#Caris_Life_Sciences#Irving#Precision_Medicine#GPSai
Caris Life Sciences Unveils Groundbreaking AI Tool for Accurate Tumor Diagnosis and Treatment Decisions
Caris Life Sciences has developed a state-of-the-art AI tool that vastly improves the accuracy of tumor diagnosis, aiding in personalized treatment decisions.
third-news.com
August 5, 2025 at 1:15 PM
newsen.bsky.social
Caris Life Sciences Confirms and Expands Insights on Tumor-Infiltrating Clonal Hematopoiesis#United_States#Caris_Life_Sciences#Irving#Precision_Oncology#Tumor-infiltrating_Clonal_Hematopoiesis
Caris Life Sciences Confirms and Expands Insights on Tumor-Infiltrating Clonal Hematopoiesis
Caris Life Sciences has validated crucial findings on tumor-infiltrating clonal hematopoiesis, addressing its impact on cancer treatment outcomes.
third-news.com
July 22, 2025 at 1:13 PM
newsen.bsky.social
Caris Life Sciences Unveils Groundbreaking Study on Blood-Based Assay for Multi-Cancer Detection#United_States#Caris_Life_Sciences#Irving#cancer_detection#Caris_Assure
Caris Life Sciences Unveils Groundbreaking Study on Blood-Based Assay for Multi-Cancer Detection
Caris Life Sciences has published a pivotal study demonstrating the effectiveness of its blood-based assay for diagnosing multiple cancers, showcasing advances in early detection and therapy selection.
third-news.com
July 8, 2025 at 10:40 AM
newsen.bsky.social
Caris Life Sciences Prices Initial Public Offering at $21.00 Per Share#USA#Caris_Life_Sciences#Irving#Precision_Medicine#AI_TechBio
Caris Life Sciences Prices Initial Public Offering at $21.00 Per Share
Caris Life Sciences has announced the pricing of its initial public offering, set at $21.00 per share, marking a significant milestone for the company.
third-news.com
June 18, 2025 at 2:17 AM
newsen.bsky.social
Caris Life Sciences Unveils Plans for Initial Public Offering in a Major Move Towards Advanced Precision Medicine#United_States#Caris_Life_Sciences#Irving#Precision_Medicine#IPO_Announcement
Caris Life Sciences Unveils Plans for Initial Public Offering in a Major Move Towards Advanced Precision Medicine
Caris Life Sciences, a key player in AI-driven precision medicine, has announced its plans for an initial public offering, aiming for shares priced between $16 and $18.
third-news.com
June 9, 2025 at 12:17 PM
newsen.bsky.social
Caris Life Sciences Pursues Initial Public Offering as AI TechBio Innovator#USA#Caris_Life_Sciences#Irving#Precision_Medicine#AI_TechBio
Caris Life Sciences Pursues Initial Public Offering as AI TechBio Innovator
Caris Life Sciences has filed a registration statement for an initial public offering of its Class A common stock, aiming for growth in precision medicine and AI integration.
third-news.com
May 23, 2025 at 10:05 PM
newsen.bsky.social
Caris Life Sciences to Showcase Groundbreaking Research at ASCO 2025 Meeting#United_States#Chicago#Caris_Life_Sciences#Precision_Oncology#ASCO_2025
Caris Life Sciences to Showcase Groundbreaking Research at ASCO 2025 Meeting
Caris Life Sciences will present 37 abstracts on precision oncology research at ASCO 2025, showcasing innovations transforming cancer treatment and patient care.
third-news.com
May 22, 2025 at 10:43 AM
newsen.bsky.social
Caris Life Sciences Introduces MET IHC Testing for Lung Cancer Treatment Standardization#United_States#Caris_Life_Sciences#Irving,_Texas#Cancer_Biomarkers#MET_IHC
Caris Life Sciences Introduces MET IHC Testing for Lung Cancer Treatment Standardization
Caris Life Sciences sets a new standard for treating non-squamous non-small cell lung cancer with its MET Immunohistochemistry testing, enhancing personalized medicine.
third-news.com
May 12, 2025 at 10:33 AM